ILM Group was founded by practicing U.S. clinicians with an extensive experience operating at the intersection of clinical practice, medical technology, and health system strategy.

Our founders have worked extensively on the expansion of advanced procedural therapies across complex healthcare environments, with direct involvement in physician education, guideline development, reimbursement strategy, and institutional adoption.

Their work spans clinical governance, health system integration, and execution at scale, informing ILM’s disciplined approach to market entry and long-term adoption.

ILM operates under direct clinical leadership to ensure that expansion decisions reflect not only commercial feasibility, but clinical integrity, economic sustainability, and reputational durability.